PRODIGY AUTOCODE
Report
- Report Number
- 3005862821-2017-00009
- Event Type
- Injury
- Date Received
- January 17, 2017
- Date of Event
- December 15, 2016
- Report Date
- December 15, 2016
- Manufacturer
- OK BIOTECH CO., LTD.
- Product Code
- NBW
- PMA / PMN Number
- K073118
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA, US
- Reporter Occupation
- OTHER
Narratives
SUSPECTED DEVICE EVALUATED BY OK BIOTECH AND CALCULATED THAT THE METER OPERATED WITHIN SPECIFICATIONS. THE STANDBY CURRENT TEST IS 1.0UA. THE CRITERIA IS <55UA. PASS; METER SETTING, AUDIO AND ALL BUTTONS FUNCTION ARE OK; TESTED THE SUSPECTED METER WITH IN HOUSE CONTROL SOLUTION AND RETAIN STRIPS (STRIP LOT NUMBER:D150110-2). THE CONTROL SOLUTION TESTS FOR LEVEL LOW ARE 64/66 MG/DL, FOR LEVEL HIGH ARE 275/271 MG/DL. THE REQUEST CONTROL SOLUTION RANGES ARE: LEVEL LOW 25~70 MG/DL; LEVEL HIGH 210~310 MG/DL. ALL RESULTS WERE WITHIN THE ACCEPTANCE RANGE. PASS; THE STRIP LOT #D150110-2 WAS MANUFACTURED ON 01/10/2015 AND EXPIRED IN 01/10/2017. OK BIOTECH RECEIVED NO COMPLAINTS FROM SAME MANUFACTURING BATCH OF STRIPS .
IT WAS REPORTED THAT MEDICAL ATTENTION WAS SOUGHT ON (B)(6) 2016 AT 7:30 AM AFTER THE END USER COULD NOT BE AWAKEN FROM HER SLEEP. AT THAT MOMENT A BLOOD GLUCOSE TEST WAS PERFORMED WITH THE PRODIGY METER WITH A RESULT OF 81 MG/DL. THE PARAMEDICS WERE CALLED AND PERFORMED A BLOOD GLUCOSE TEST WITH THEIR METER AND RECEIVED A RESULT OF 42 MG/DL. THE END USER WAS TRANSPORTED TO THE ER AND COULD NOT REMEMBER WHAT TREATMENT WAS ADMINISTERED TO ASSIST WITH STABILIZING HER BLOOD GLUCOSE LEVELS. UPON DISCHARGE THE END USER WAS INSTRUCTED TO DECREASE HER LEVEMIR TO 5 UNITS AND EAT A SNACK BEFORE BED. NO ADDITIONAL INFORMATION WAS PROVIDED AS IT RELATES TO THE MEDICAL EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 41353 | PRODIGY AUTOCODE | BLOOD GLUCOSE MONITORING DEVICE | NBW | OK BIOTECH CO., LTD. | 51850 | 54800 - D150110-2 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Required Intervention | AMLODIPINE| ASPIRIN| BUMETANIDE| CALCITRIOL| CITALOPRAM| GABAPENTIN| HYDRALAZINE| HYDROCODONE| IRON| ISOSORBIDE| LEVEMIR E. INITIAL| NOVOLOG| OMEGA 3| PRAVASTATIN| VITAMIN D3 |